The white paper contains the highest priorities and a research framework for the systemic amyloidosis diseases. This consensus document was developed through a rigorous process with the participation of 71 international experts from academic, clinical, regulatory, patient advocacy, health policy, industry, and other key areas. This publication is intended to identify, improve and accelerate a drug development pathway for the systemic amyloidosis diseases.
Advancing Amyloidosis: A Research Roadmap
ARC Diagnostic AlgorithmTools, Physicians
Hereditary ATTR: Sean’s storyPatient Stories
Get the latest Amyloidosis news and research from ARC. Join our newsletter